Skip to main content
Equibles

GIFLF · Grifols SA

Track GIFLF — free

Use GIFLF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GIFLF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.13 At close · Sep 15
Rebalance outlook locked
Market Cap
$5.00B
Shares
680.58M
Volume · Sep 15 5000 Avg daily vol (9 sessions) 1927

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$11.13 Open$11.13 Day$11.13–11.13 Available close range$10.13–12.90 Avg vol 30d4K Last earningsJul 28, 2026 DataJan 2020–Sep 2026

The closing range uses available history since Nov 21, 2025; less than a full year is stored.

Up next

Next earnings call
Oct 23, 2026 Est · unconfirmed · in 2 wks
Q1 2026 earnings call transcript
call held May 7, 2026

Guidance & track record

Latest guidance · from the Earnings Call filed Mar 31, 2026
Adjusted EBITDA margin · full year 2026 Non-GAAP Initiated at least 25%
Adjusted EBITDA growth · full year 2026 Non-GAAP Initiated 5% – 9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $11 › 200d $13 — 200d above 50d
Institutional flow Accumulating
2 of 164 funds reported for Sep 30 · net +6.6K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
164 holders — mid 3-yr range
Price context
position in its available closing range
Range low $10 Now $11 · 36% Range high $13
vs 200-day avg -17% vs 50-day avg +6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - General — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GIFLF
Grifols SA
this stock
$5.00B — — — —
LLY
ELI LILLY & Co
 $1.11T +7.7% +44.7% 39.7 0.8%
JNJ
Johnson & Johnson
 $653.61B +23.1% +6.0% 31.5 0.9%
ABBV
AbbVie Inc.
 $466.80B +16.7% +8.6% 74.6 1.1%
MRK
Merck & Co., Inc.
 $367.07B +34.8% +1.3% 119.0 1.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
165
% held
21.0%
Reported
2 of 164
Top holder
BRANDES INVESTMENT PARTNE…
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
290
Value
$2.3K
As of
Sep 8, 2026
View
Smart Money
Congressional Trades Sell
Member
Daniel Goldman
Amount
$1.0K–$15.0K
Traded
Mar 31, 2023
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 30, 2026
This year
12
View
Earnings & Events
Webcasts
Last webcast
Jul 28, 2026
View

Performance

5D 20D 120D MTD YTD
GIFLF +8.6% +6.5% +40.9% -5.4% -4.6%
SPY -1.1% -2.0% +16.0% -1.3% +11.1%
vs SPY +9.7% +8.5% +24.9% -4.1% -15.6%
Key facts CIK 1438569 CUSIP 398438408 Visit website Investor relations